Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
McKesson
Daiichi Sankyo
Boehringer Ingelheim
Cantor Fitzgerald
Farmers Insurance

Generated: August 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,633,194

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,633,194
Title:Pharmaceutical composition of piperazine derivatives
Abstract: The present invention relates to a liquid composition containing an active substance belonging to the family of substituted benzhydryl piperazines with reduced amounts of preservatives.
Inventor(s): Fanara; Domenico (Wanze, BE), Scouvart; Jean (Brussels, BE), Poulain; Claire (Brussels, BE), Deleers; Michel (Linkebeek, BE)
Assignee: UCB Pharma, S.A. (Brussels, BE)
Application Number:10/599,451
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,633,194
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 8,633,194

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sanofi Aventis Us XYZAL ALLERGY 24HR levocetirizine dihydrochloride SOLUTION;ORAL 209090-001 Jan 31, 2017 OTC Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,633,194

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
04016519Jul 14, 2004
PCT Information
PCT FiledJuly 06, 2005PCT Application Number:PCT/EP2005/007340
PCT Publication Date:January 19, 2006PCT Publication Number: WO2006/005507

International Family Members for US Patent 8,633,194

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 049846 ➤ Sign Up
Austria 443512 ➤ Sign Up
Australia 2005261953 ➤ Sign Up
Brazil PI0513257 ➤ Sign Up
Canada 2573662 ➤ Sign Up
China 100508981 ➤ Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Harvard Business School
Mallinckrodt
Teva
Julphar
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.